In a January 2013 Press Release, TNI BioTech was given exclusive rights to patent and formulate LDN for pediatric Crohn's disease. This is the first step in widespread approval for LDN.
This site best viewed in: Google Chrome, MS Edge, and Firefox. Turn off ad blockers and DuckDuckGo to view Elaine's books.
Graves' Disease and Autoimmune Disease Education Copyrighted by Elaine Moore © 2008-2022 | All Rights Reserved. All writing and images copyrighted. Copyright Notices and Disclaimer
The Elaine-Moore.com site was developed and designed by VESWeb.com